Ausgabe 1/2012
Inhalt (41 Artikel)
Risk prediction models of breast cancer: a systematic review of model performances
Thunyarat Anothaisintawee, Yot Teerawattananon, Chollathip Wiratkapun, Vijj Kasamesup, Ammarin Thakkinstian
Ultrasonographic differentiation of malignant from benign breast lesions: a meta-analytic comparison of elasticity and BIRADS scoring
Gelareh Sadigh, Ruth C. Carlos, Colleen H. Neal, Ben A. Dwamena
A diagnostic gene profile for molecular subtyping of breast cancer associated with treatment response
Oscar Krijgsman, Paul Roepman, Wilbert Zwart, Jason S. Carroll, Sun Tian, Femke A. de Snoo, Richard A. Bender, Rene Bernards, Annuska M. Glas
Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor–positive early breast cancer patients
Johanna G. H. van Nes, Esther M. de Kruijf, Hein Putter, Dana Faratian, Alison Munro, Fiona Campbell, Vincent T. H. B. M. Smit, Gerrit-Jan Liefers, Peter J. K. Kuppen, Cornelis J. H. van de Velde, John M. S. Bartlett
Targeted and intracellular triggered delivery of therapeutics to cancer cells and the tumor microenvironment: impact on the treatment of breast cancer
Vera Moura, Manuela Lacerda, Paulo Figueiredo, Maria L. Corvo, Maria E. M. Cruz, Raquel Soares, Maria C. Pedroso de Lima, Sérgio Simões, João N. Moreira
Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44+ human breast cancer cells
Alysha K. Croker, Alison L. Allan
Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy
C. Panis, A. C. S. A. Herrera, V. J. Victorino, F. C. Campos, L. F. Freitas, T. De Rossi, A. N. Colado Simão, A. L. Cecchini, R. Cecchini
The tamoxifen metabolite norendoxifen is a potent and selective inhibitor of aromatase (CYP19) and a potential lead compound for novel therapeutic agents
Wenjie Jessie Lu, Cong Xu, Zifan Pei, Abdelrahman S. Mayhoub, Mark Cushman, David A. Flockhart
RAD50 and NBS1 are not likely to be susceptibility genes in Chinese non-BRCA1/2 hereditary breast cancer
Min He, Gen-Hong Di, A-Yong Cao, Zhen Hu, Wei Jin, Zhen-Zhou Shen, Zhi-Ming Shao
Enhancement of doxorubicin cytotoxicity of human cancer cells by tyrosine kinase inhibition of insulin receptor and type I IGF receptor
Xianke Zeng, Hua Zhang, Annabell Oh, Yan Zhang, Douglas Yee
Physical activity and breast cancer survival: an epigenetic link through reduced methylation of a tumor suppressor gene L3MBTL1
Hongmei Zeng, Melinda L. Irwin, Lingeng Lu, Harvey Risch, Susan Mayne, Lina Mu, Qian Deng, Luca Scarampi, Marco Mitidieri, Dionyssios Katsaros, Herbert Yu
Anti-tumor effects of a novel retinoic acid metabolism blocking agent VN/14-1 in the N-methyl-N-nitrosourea-induced rat mammary carcinoma model and its effects on the uterus
Paul E. Goss, Shangle Qi, Haiqing Hu, Lalji K. Gediya, Puranik Purushottamachar, Abhijit M. Godbole, Vincent C. O. Njar
Alteration of Y-box binding protein-1 expression modifies the response to endocrine therapy in estrogen receptor-positive breast cancer
Tokiko Ito, Shinobu Kamijo, Hiroto Izumi, Kimitoshi Kohno, Jun Amano, Ken-ichi Ito
Genetic heterogeneity in HER2 testing may influence therapy eligibility
Barbara Bernasconi, Anna Maria Chiaravalli, Giovanna Finzi, Katia Milani, Maria Grazia Tibiletti
Histologic findings in normal breast tissues: comparison to reduction mammaplasty and benign breast disease tissues
Amy C. Degnim, Daniel W. Visscher, Tanya L. Hoskin, Marlene H. Frost, Robert A. Vierkant, Celine M. Vachon, V. Shane Pankratz, Derek C. Radisky, Lynn C. Hartmann
Expressions of individual PHDs associate with good prognostic factors and increased proliferation in breast cancer patients
Emmi Peurala, Peppi Koivunen, Risto Bloigu, Kirsi-Maria Haapasaari, Arja Jukkola-Vuorinen
Smac-mimetic compound SM-164 induces radiosensitization in breast cancer cells through activation of caspases and induction of apoptosis
Dong Yang, Yongchao Zhao, Amy Y. Li, Shaomeng Wang, Gongxian Wang, Yi Sun
Role of Src in breast cancer cell migration and invasion in a breast cell/bone-derived cell microenvironment
Brant Pohorelic, R. Singh, S. Parkin, K. Koro, A.-D. Yang, C. Egan, A. Magliocco
Erratum to: Role of Src in breast cancer cell migration and invasion in a breast cell/bone-derived cell microenvironment
Brant Pohorelic, R. Singh, S. Parkin, K. Koro, A.-D. Yang, C. Egan, A. Magliocco
Inhibition of EGFR phosphorylation in a panel of human breast cancer cells correlates with synergistic interactions between gefitinib and 5′-DFUR, the bioactive metabolite of Xeloda®
Maria Ait-Tihyaty, Zakaria Rachid, Catalin Mihalcioiu, Bertrand J. Jean-Claude
Health-related quality of life, psychological distress, and adverse events in postmenopausal women with breast cancer who receive tamoxifen, exemestane, or anastrozole as adjuvant endocrine therapy: National Surgical Adjuvant Study of Breast Cancer 04 (N-SAS BC 04)
Hiroyuki Takei, Shozo Ohsumi, Kojiro Shimozuma, Megumi Takehara, Kimito Suemasu, Yasuo Ohashi, Yasuo Hozumi
Dose-dependent change in biomarkers during neoadjuvant endocrine therapy with fulvestrant: results from NEWEST, a randomized Phase II study
Irene Kuter, Julia M. W. Gee, Roberto Hegg, Christian F. Singer, Rajendra A. Badwe, Elizabeth S. Lowe, Ugochi A. Emeribe, Elizabeth Anderson, Francisco Sapunar, Pauline Finlay, Robert I. Nicholson, José Bines, Nadia Harbeck
Small node-negative (T1b-cN0) invasive hormone receptor-positive breast cancers: Is there a subpopulation that might have benefit from adjuvant chemotherapy?
Yeon Hee Park, Seock-Ah Im, Eun Yoon Cho, Yoon-La Choi, Jeong Eon Lee, Seok Jin Nam, Jung Hyun Yang, Jin Seok Ahn, Young-Hyuck Im
Prognostic impact of placenta growth factor and vascular endothelial growth factor A in patients with breast cancer
Else Maae, Dorte Aalund Olsen, Karina Dahl Steffensen, Erik Hugger Jakobsen, Ivan Brandslund, Flemming Brandt Sørensen, Anders Jakobsen
Prospective study of breast tomosynthesis as a triage to assessment in screening
Daniela Bernardi, Stefano Ciatto, Marco Pellegrini, Paolina Tuttobene, Carmine Fanto’, Marvi Valentini, Stefano Di Michele, Paolo Peterlongo, Nehmat Houssami
Characterization of four novel BRCA2 large genomic rearrangements in Spanish breast/ovarian cancer families: review of the literature, and reevaluation of the genetic mechanisms involved in their origin
Gorka Ruiz de Garibay, Sara Gutiérrez-Enríquez, Pilar Garre, Sandra Bonache, Atocha Romero, Laura Palomo, Ana Sánchez de Abajo, Javier Benítez, Judith Balmaña, Pedro Pérez-Segura, Eduardo Díaz-Rubio, Orland Díez, Trinidad Caldés, Miguel de la Hoya
Black–white differences in receipt and completion of adjuvant chemotherapy among breast cancer patients in a rural region of the US
Joseph Lipscomb, Theresa W. Gillespie, Michael Goodman, Lisa C. Richardson, Lori A. Pollack, A. Blythe Ryerson, Kevin C. Ward
Disparities in breast cancer care delivery: solving a complex puzzle
Christopher R. Friese
Incidence of reduced chemotherapy relative dose intensity among women with early stage breast cancer in US clinical practice
Derek Weycker, Rich Barron, John Edelsberg, Alex Kartashov, Gary H. Lyman
Higher expression of androgen receptor is a significant predictor for better endocrine-responsiveness in estrogen receptor-positive breast cancers
Seho Park, Hyung Seok Park, Ja Seung Koo, Woo Ick Yang, Seung Il Kim, Byeong-Woo Park
Favorable outcome associated with an IGF-1 ligand signature in breast cancer
Lina Mu, David Tuck, Dionyssios Katsaros, Lingeng Lu, Vincent Schulz, Sudhir Perincheri, Guido Menato, Luca Scarampi, Lyndsay Harris, Herbert Yu
Structural/organizational characteristics of health services partly explain racial variation in timeliness of radiation therapy among elderly breast cancer patients
Stephanie B. Wheeler, William R. Carpenter, Jeffrey Peppercorn, Anna P. Schenck, Morris Weinberger, Andrea K. Biddle
Assessing the added value of breast tumor markers in genetic risk prediction model BRCAPRO
Swati Biswas, Neelam Tankhiwale, Amanda Blackford, Angelica M. Gutierrez Barrera, Kaylene Ready, Karen Lu, Christopher I. Amos, Giovanni Parmigiani, Banu Arun
Willingness to use tamoxifen to prevent breast cancer among diverse women
Celia Patricia Kaplan, Sue E. Kim, Sabrina T. Wong, George F. Sawaya, Judith M. E. Walsh, Eliseo J. Pérez-Stable
Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study
Annette Wigertz, Johan Ahlgren, Marit Holmqvist, Tommy Fornander, Jan Adolfsson, Henrik Lindman, Leif Bergkvist, Mats Lambe
Social networks, social support and burden in relationships, and mortality after breast cancer diagnosis
Candyce H. Kroenke, Yvonne Michael, Hilary Tindle, Elizabeth Gage, Rowan Chlebowski, Lorena Garcia, Catherine Messina, JoAnn E. Manson, Bette J. Caan
Pregnancy occurring during or following adjuvant trastuzumab in patients enrolled in the HERA trial (BIG 01-01)
Hatem A. Azim Jr., Otto Metzger-Filho, Evandro de Azambuja, Sibylle Loibl, Florine Focant, Ekaterina Gresko, Mounir Arfi, Martine Piccart-Gebhart
Evaluation of RAD51C as cancer susceptibility gene in a large breast-ovarian cancer patient population referred for genetic testing
K. De Leeneer, M. Van Bockstal, S. De Brouwer, N. Swietek, P. Schietecatte, N. Sabbaghian, J. Van den Ende, S. Willocx, K. Storm, B. Blaumeiser, C. J. Van Asperen, J. T. Wijnen, K. Leunen, E. Legius, G. Michils, G. Matthijs, M. J. Blok, E. Gomez-Garcia, A. De Paepe, M. Tischkowitz, B. Poppe, K. Claes
Not so fast: the use of incomplete data to devalue the role of mammography screening
Daniel B. Kopans
Erratum to: Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis
Sean D. McAllister, Ryuichi Murase, Rigel T. Christian, Darryl Lau, Anne J. Zielinski, Juanita Allison, Carolina Almanza, Arash Pakdel, Jasmine Lee, Chandani Limbad, Yong Liu, Robert J. Debs, Dan H. Moore, Pierre-Yves Desprez